Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis
Condition: Lyme Borreliosis Interventions: Biological: VLA15; Biological: Placebo Sponsor: Valneva Austria GmbH Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials